Ligand Pharmaceuticals Inc., 10% Owner at Viking Therapeutics, Inc. (VKTX), sold 164,488 shares at $8.02 ($1.3M) on 2020-08-25, disclosed to the SEC on 2020-08-27.
Open-market sale of $1.3M VKTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.02 | 70,000 | $561K | 42.3% |
| 2 | $8.11 | 94,488 | $766K | 57.7% |
| Total | $8.07 avg | 164,488 | $1.3M | 100% |
| Filing → |